That new Amgen drug targets a human protein that’s mostly only used during embryonic development. I think it’s expressed by most cancer cells in maybe around 0.2% of cancer cases. In many of those cases, some of the cancer cells will stop producing it.
Most potential targets have worse side effects and/or are less common.
That new Amgen drug targets a human protein that’s mostly only used during embryonic development. I think it’s expressed by most cancer cells in maybe around 0.2% of cancer cases. In many of those cases, some of the cancer cells will stop producing it.
Most potential targets have worse side effects and/or are less common.